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 ABSTRACT 
Background: Greater integration of patient-centered outcomes in surgery remains 
paramount in the current medical climate. Patient-reported outcomes have emerged as 
a useful tool to assess subjective outcomes such as pain, function, and quality of life. 
In order to determine areas of crucial research on patient-reported outcomes and 
advance cross-disciplinary collaboration, a research agenda was created through a 
Delphi survey of stakeholders in collaboration with the inaugural Patient-Reported 
Outcomes (PROS) in Surgery Conference. In the second part of this study, a decision 
model was created to simulate patient-centered outcomes after low anterior resection 
for rectal cancer. Randomized controlled trials support the use of defunctioning 
ileostomies as it reduces the morbidity and mortality of anastomotic leakage; however, 
they are associated with greater risk for readmission, complications (bowel 
obstruction, stomal hernia) and impact patient quality of life. Assimilating these data 
can be difficult for clinicians. To this end, a decision analysis was developed to 
evaluate the impact of defunctioning ileostomy on patient quantity and quality of life.  
 
Methods: To create a research agenda, an iterative Web-based interface was used to 
create a conference-based, modified Delphi survey. Participation was limited to PROS 
conference registrants, which included surgeons, PRO researchers, payers and other 
stakeholders. In the first round, research items were generated from qualitative review 
of responses to open-ended prompts. In the second and third rounds, items were 
ranked using a Likert scale. The top 20 items by mean rating were selected for the 
research agenda. In the decision analysis, a decision tree compared defunctioning 
ileostomy creation to no defunctioning ileostomy creation after low anterior resection 
for rectal cancer. The base case for model analysis was a 65-year-old man with 
resectable, stage II-III rectal cancer at 8cm from the anal verge status post neoadjuvant 
 chemoradiation therapy. Long term health states after surgery were stoma, no stoma or 
death. The primary outcome measure was quality-adjusted life-years (QALYs). Model 
probabilities and health-state utilities were obtained from the literature using a priori 
search criteria. The probabilities and utilities were varied over their plausible ranges 
through sensitivity analyses of one, two and three variables.  
Results: In round one of the Delphi Survey, participants submitted 459 items, which 
were reduced through qualitative review to 53 distinct items across seven themes of 
PROs research. A research agenda was formulated after two successive rounds of 
ranking. The research agenda identified three themes important for future PROs 
research in surgery: (1) PROs in the decision-making process, (2) integrating PROs 
into the EHR and (3) measuring quality in surgery with PROs. For the decision 
analysis, defunctioning ileostomy creation was the preferred strategy (8.81 vs. 8.73 
QALYs). In one-way sensitivity analyses, defunctioning ileostomy remained the 
preferred strategy over the plausible range of all variables with four exceptions: if the 
risk of clinical leak was less than 8.9%, if the leak-associated mortality was less than 
4.1 %, if the one-year ileostomy reversal rate was less than 70% or if the utility of a 
stoma was less than 0.69.  
 
Conclusion: A research agenda on PROs in surgery was created using a modified 
Delphi survey of stakeholders that will help researchers, surgeons, and funders 
identify crucial areas of future PROs research in surgery. In the decision analysis, low 
anterior resection with defunctioning ileostomy is the preferred treatment strategy, 
however for a subset of patients, no ileostomy may be the preferred if patient 
perception and risk are accounted. The quality of life with a stoma, the probability of a 
clinical leak and the rate of stoma reversal significantly impacted model preferences, 
and should be considered in decisions on ileostomy formation during rectal resection.  
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CHAPTER ONE 
 
INTRODUCTION 
PROs, as defined by the FDA, are “any report of the status of a patient’s health 
condition that comes directly from the patient, without interpretation of the patient’s 
response by a clinician or anyone else.”1  In practice, this entails measuring a 
subjective outcome like function after knee arthroplasty with a questionnaire.  
Publications on patient-reported outcomes (PROs) in the surgical literature have 
tripled during the last decade.  The growing recognition among surgeons that many 
postoperative outcomes like functional improvement or symptom severity are best 
measured by the patient and the increased availability of measures for historically 
subjective topics have undoubtedly contributed to this surge in publications.2–4 PROs 
now play an important role in the planning of comparative effectiveness research and 
are currently used as primary outcomes in surgical trials.5 The Institute of Medicine 
and the National Quality Forum have long advocated that patient-centered care should 
be a requirement in modern health care, and this perspective has influenced health care 
deliberations during the last decade.6 Furthermore, the Affordable Care Act has 
encouraged patient-reported data collection in surgery by creating new payment 
models through the Centers for Medicaid and Medicare Services (CMS) and by 
targeted funding of research from the Patient-Centered Outcomes Research Institute.7,8 
These new models underscore the growing importance of PROs in surgery.  
Despite the potential value of PROs in surgical care, many methodological and 
logistical concerns remain.9 Addressing these issues is difficult in a research climate of 
increasingly scarce funding.10 Thus, researchers and funding agencies need input and 
clarity from stakeholders, in order to better prioritize research and improve 
collaboration between institutions. Furthermore, options for surgical techniques and 
technologies are rapidly expanding while healthcare resources are shrinking. To better 
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understand the outcomes of surgery from the patient perspective, there is no better 
time than now for the surgical and research communities to come together and reach 
consensus regarding the most important and timely issues with PROs research in 
surgery.   
To address these issues, the Patient-Reported Outcomes in Surgery Conference 
was formed, with sponsorship from The Plastic Surgery Foundation and the Agency 
for Healthcare Research and Quality. The conference brought together stakeholders 
from diverse fields, including payers, patient advocates, surgeons, researchers, 
industry representatives, regulators, and health information technology vendors. The 
two-day conference was held in Washington, D.C. (Jan 29-30, 2015) and included 
panel discussions on current PROs research in surgery within the areas of clinical care, 
comparative effectiveness, patient access, psychometric development, surgical trials, 
and quality, as well mapping out the future directions for each field. The specific goals 
of the conference were to improve the accessibility and interpretability of PROs data 
for patients and providers, to develop a consensus around methodological issues of 
PROs measurement, and to develop a research agenda for PROs measurement in 
surgery. The formation of a research agenda should prioritize research questions 
deemed to be timely and important by stakeholders to guide future collaboration and 
funding. To meet this aim, the conference leadership conducted a Delphi survey of 
stakeholders to develop an agenda on future PROs research in surgery. 
  
METHODS 
This study used a modified Delphi survey to achieve formal group consensus, 
maximizing dialogue through anonymous, structured feedback.11,12 To facilitate the 
use of the Delphi model, an expert panel was assembled before the opening of the 
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conference. The panel, composed of conference leaders and methodological experts, 
developed the study schema and consensus criteria on the basis of a three-round, Web-
based survey (Figure 1.1). The study was approved by the Memorial Sloan Kettering 
Cancer Center Institutional Review Board (prospective waiver X15-004). 
 
 
Figure 1.1 Flow chart for the three rounds of the modified Delphi survey 
Emails containing a link to a Web-based survey were distributed to all 
conference registrants 1 week before the start of the conference (round one), which 
was held January 29–30, 2015. Participants were asked to anonymously identify 
timely and important PROs research topics through seven open-ended questions 
related to clinical care, comparative effectiveness, patient satisfaction, and quality 
metrics. There was no limit to the length of the responses. Item submissions were 
reviewed in parallel by two researchers (M.P. and W.C.). This involved separating 
RESEARCH AGENDA
ROUND THREE: Final Ranking
Rank top 20
EXPERT PANEL
ROUND TWO: Item Reduction
Rank top 30 items, Additional responses
EXPERT PANEL
ROUND ONE: Item Generation
Open-ended Questions
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compound responses into individual items, summarizing submissions into concise 
items, and categorizing items into generic themes. After all submissions were 
reviewed, identical items were deleted and similar items with overlapping content 
were consolidated into broader concepts. The expert panel then evaluated the 
consistency of each researcher’s item reduction and endorsed the selection of research 
items for round two. 
All conference attendees were invited to participate in a Web-based survey 
during the conference (round two). Participants were given the final research items 
from round one, in randomized order, and were asked to rank the items by research 
importance using a 5-point Likert scale, with high and low research priority as 
anchors. In addition, an open-ended question prompt at the conclusion of the survey 
allowed participants to submit additional research questions. Mirroring the process in 
round one, all new research questions submitted in round two were subjected to 
qualitative review and consolidation into final research items. Round two concluded 
with the completion of the conference. 
Following the conference, all attendees were asked, via email, to participate in 
a Web-based survey, regardless of whether they participated in previous rounds. Email 
reminders to complete the survey were distributed weekly, and each registrant was 
limited to one survey response each. The top 30 items by mean priority score from 
round two, along with new item submissions, were distributed for final ranking by 
research priority, in order to reach the a priori goal of a 20 item research agenda. To 
reduce the possibility of a ceiling effect, a 3-point Likert scale was utilized in the final 
round and participants were encouraged to rate only 10 items as ‘high research 
priority’. As in round two, item order was randomized. The top 20 items by mean 
Likert score were selected as the consensus research agenda. 
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RESULTS 
Of the 143 people registered for the conference, 137 provided valid email 
addresses. Potential subjects were invited to participate during each round. There was 
a wide range of attendants including individuals from several surgical subspecialties, 
payers, regulators and patient advocates with the three most common groups identified 
as being plastic surgeons (19%), general surgeons (13%) and researchers (17%).  
Table 1.1 presents the basic demographic characteristics of respondents by round. 
During item generation (rounds one and two), participants were given the option to 
specify their occupation (Table 1.2). Specific occupation demographics were not 
collected during round three as there was a desire to keep the survey as short as 
possible in order to increase response rates. In the first round, 83 participants (61% of 
conference registrants with email addresses) submitted 356 responses to open-ended 
questions. After review, a total of 459 research items were submitted, with a mean of 
5.5 items submitted per participant.  
 
Table 1.1 Characteristics of survey responders by round 
 
Characteristic 
Round 
One Two Three 
Registrant %, (no.) 61 (83) 39 (54) 42 (59) 
Age    
   <40 49 39 42 
   41–60 39 44 51 
   ≥61 12 17 7 
Conference role    
   Speaker 18 24 26 
   Registrant 82 76 74 
Occupation    
   Surgeon 64 54 59 
   Non-surgeon 36 46 41 
PROs experience    
   <3 years  40 35 44 
   4–6 years 22 17 17 
   >7 years 39 48 39 
Data are % of conference registrants with a valid email address (N=137). Percentage totals may not equal 100 
due to rounding. PROs, patient-reported outcomes. 
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Table 1.2 Occupations of conference registrants and survey responders
8 
 
Table 1.2 Occupations of conference registrants and survey responders 
 
Occupation 
Conference 
Registrants 
 
Round 1 
 
Round 2 
Surgeon    
   Breast Surgery 7 2 0 
   Colorectal Surgery 7 7 2 
   General Surgery 19 12 8 
   Neurosurgery 1 1 1 
   Orthopedic Surgery 9 1 0 
   Otolaryngology 7 2 2 
   Plastic Surgery 28 14 9 
   Surgical Oncology 4 1 0 
   Thoracic Surgery 2 0 1 
   Urology 8 3 1 
   Vascular Surgery 1 0 0 
Nonsurgeon    
   Health IT Vendor 2 2 2 
   Funding Agency 2 1 1 
   Federal Regulator 5 1 0 
   Patient Advocate 2 1 1 
   Policymaker 2 0 1 
   Researcher 25 20 15 
   Research Fellow/Trainee 4 2 4 
   Research Staff/Manager 8 3 2 
   Total 143 73 50 
Disclosure of specific occupations remained optional. Thus, the number of 
participants who disclosed their occupation in Rounds 1 and 2 was less than the total 
number of participants for both rounds.   
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After item reduction was performed and the expert panel reviewed the results, 
there were 53 items within seven themes: clinical care, comparative effectiveness, data 
management, ethics, performance measurement, education, and other. In the second 
round, 54 participants (39% of emailed registrants) responded to email invitations 
during the conference. Responders ranked the 53 items by research priority and 
submitted 9 new items, which were reviewed and consolidated to 3 new items. In the 
third round, 57 participants (42% of emailed registrants) responded to survey 
invitations. The top 20 items from round three were selected as the consensus research 
agenda for future PRO research (Table 1.3). Ranking of item importance remained 
stable between rounds, with only 2 items from the top 20 of Round 2 failing to make 
the final research agenda. Stakeholder participation from Rounds 2 and 3 was 
predominantly from experienced PROs researchers with more than 60% of 
participants reporting > 7 years experience.  
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Table 1.3 The final research agenda, from 459 items initially submitted 
 
Rank Mean Item 
1  2.52 Impact of PROs on patient and/or provider decision making. 
2  2.49 Accuracy of measuring quality in surgery with PROs versus clinical 
quality metrics. 
3  2.46 Efficacy of patient-reported performance measures to reduce costs and 
improve quality. 
4  2.41 Improve PROs data collection, integration, and presentation into the 
EHR. 
5  2.36 Impact of patient expectations on their satisfaction with surgery. 
6  2.35 Optimize presentation of PROs data to providers for rapid interpretation 
and action. 
6  2.35 Efficient integration of PROs data collection and reporting into the 
clinical workflow. 
8  2.33 Determine optimal method for transitioning PROMs from research tools 
to performance measures. 
9  2.29 Create systems that use PROs data to alert providers to patient needs and 
flag actionable items. 
10  2.27 Influence of patient-reported data on patient satisfaction with decision-
making. 
11  2.23 Establish PROs benchmarks in surgical care. 
12  2.22 Effect of preoperative education on patient satisfaction with surgery. 
13  2.21 Improve utilization of PROs among nonacademic providers and 
institutions. 
14  2.19 Influence of patient-reported data on patient satisfaction with clinical 
care. 
14  2.19 Develop strategies for better patient engagement and improved response 
rates. 
16  2.17 Accuracy of patient-reported data as a primary outcome in surgical trials. 
17  2.15 Role of PROs data in patient education. 
18  2.13 Explore if patient access to PROs data improves quality. 
18  2.13 Risk adjust and standardize PROs data. 
20  2.11 Identify barriers to successful implementation of PROs measures in 
clinical trials. 
EHR, electronic health record; PROs, patient-reported outcomes; PROMs, patient-
reported outcome measures. 
12 
 
DISCUSSION 
Using a modified Delphi approach, we engaged an international stakeholder 
group of surgeons, researchers, patient advocates, funding agency representatives, 
health information technology vendors, and regulators to reach consensus on future 
PROs research priorities in surgery. The final results of the survey contain the top 20 
items from over 450 topics initially submitted by participants. Our results represent the 
first consensus-driven, surgery-focused PRO research agenda to date. Within the 
research agenda, three themes emerged as priorities for future research in surgery: (1) 
PROs in the surgical decision-making process, (2) challenges to integration of PROs 
in the electronic health record (EHR), and (3) PROs and the measurement of quality 
(Figure 1.2). Among all items, the decision-making process was rated of high 
importance, with “Impact of PROs on patient and/or provider decision-making” the 
top-ranked item for both rounds.
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Figure 1.2 Most important themes for PROs research in surgery  
identified from the Delphi survey 
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Priority 1:  Incorporating PRO data into the Decision Making Process 
It is not surprising that the use of PROs in the clinical decision-making process 
was the highest importance. Decision-making in surgery has traditionally relied on 
surgeon experience and established objective measures such as 30-day mortality and 
hospital length of stay. Although currently underutilized, PROs have proven to be 
effective at measuring subjective outcomes after surgery.13,14 In this respect, PROs 
data provide an added dimension to the evaluation of new surgical techniques and 
technology, which may enable surgeons to better understand subjective outcomes. For 
example, outcomes in randomized controlled trials comparing open and laparoscopic 
hernia repair techniques have previously focused on visual analogue scores of pain, 
hernia recurrence, complications, and operative time.15,16 As the differences between 
emerging techniques become more nuanced (e.g., robotic vs. laparoscopic), traditional 
measures may be insensitive to improvements in patient disability and well-being, 
both of which are central to arguments for minimally invasive surgery. Additionally, 
the inclusion of patients in shared decision-making requires health care that aligns 
with patient preferences and values.17 Routine and accurate measurement of PROs in 
surgical trials and clinical care provides a valued outcome for surgeons and expands 
patient involvement in decision-making. 
Improving decision-making in surgery will require more than just greater 
implementation of PROs in surgical trials and clinical care. This study identified 
problematic aspects within the theoretical framework for decision-making—
specifically, the relationship between decision-making and patient expectations, 
education, and satisfaction. Understanding the effects of patient expectations on the 
decision-making process requires accurate measurement of expectations, as well as 
honest assessment of the ability to recalibrate these expectations through preoperative 
education.18 A randomized trial of hip and knee arthroplasties showed that 
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preoperative education can influence patient expectations of postoperative recovery.19 
Furthermore, Ho et al. reported that patient satisfaction with preoperative information 
was the strongest predictor of satisfaction with the overall outcome—stronger even 
than the method of surgery and whether complications occurred.20 Yet, thus far, 
patient expectations have inconsistently correlated with patient satisfaction after 
surgery, and there is no accepted method for capture of perioperative expectations.21 
Studying the relationship between treatment decision-making and patient education, 
expectations, and satisfaction has become paramount, given that patient satisfaction, 
which has been measured for the past decade, is now being used to calibrate surgeon 
and institutional reimbursement.22 Future research will need to further explore the 
theoretical framework for the decision-making process and identify measurable factors 
that surgeons and institutions can use to improve care.  
Priority 2:  Integrating PRO data into the Electronic Health Record 
Concerns remain regarding the integration of PROs into the EHR. Paper 
administration and processing of PROs can be time-consuming, costly, and too 
burdensome for a busy surgical practice. EHR integration improves the logistics of 
administration, although it raises additional concerns related to the security of patient 
and provider information. Existing research has focused primarily on PROs 
measurement, rather than on the EHR interface with patients and providers.23 Effective 
systems must optimize the presentation of PROs data to enable surgeons to effectively 
interpret this information for decision-making. Likewise, enhanced feedback to 
patients may help validate the time commitment required to complete patient-reported 
measures and may potentially improve patient response rates. Without significant 
collaborative efforts to develop and improve EHR platforms, the effective use of 
patient-reported data by providers is unlikely to increase.  
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The NIH Patient Reported Outcomes Measurement Information System 
(PROMIS) may provide some insight for institutions collaborating on the electronic 
integration of PROs data collection and presentation. As a collective effort between 
institutions, PROMIS uses a centralized, Web-based system for PROs data collection 
and features immediate, standardized scoring using a shared item bank.24,25 Despite the 
success of PROMIS with electronic administration and scoring across multiple 
institutions, they are not uniformly calibrated nor validated for measuring the impact 
of surgical procedures. Future systems that measure PROs in surgery should 
incorporate the advances made by PROMIS, as well as address the issues identified by 
our Delphi survey, including presentation of PROs data to patients that is responsive 
to education level and language abilities, enabling easy interpretation by surgeons for 
immediate action, and improving the integration of PROs systems into the EHR.  
Priority 3:  Patient Reported Outcomes and Quality Assessment 
PROs and the measurement of quality emerged as the final theme from the 
Delphi survey and raised concerns about the validity, efficacy, and risk adjustment of 
PROs measures in surgery. Foremost, the survey identified the validity of measuring 
quality with PROs versus traditional clinical outcome measures as a significant 
consideration for stakeholders. Moreover, the efficacy of PROs instruments to 
improve quality and lower costs has not been extensively studied. System-wide 
introduction of PROs instruments should follow thoughtful research initiatives that 
demonstrate their effectiveness. To address this need for validation, the CMS 
Innovation Center could be a potential resource in evaluating the efficacy of selected 
PROs measures to improve quality, as it has already seen success in assessing new 
reimbursement strategies for Accountable Care Organizations.22 Emerging evidence 
has begun to show a correlation between patient satisfaction and surgical outcomes, 
however comparison of selected PROs measures between providers, surgical groups, 
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and institutions will require thorough risk and case adjustment.26 Furthermore, to 
alleviate potential skepticism within the surgical community, the establishment of 
benchmarks will necessitate adequate transparency with regard to reasoning and 
methodologies. Successful use of PROs in performance measurement of surgery will 
require a thoughtful and open collaboration among stakeholders. 
 Measuring performance with PROs, however, is not a new concept. During the 
past decade, the UK National Health Service Patient Reported Outcome Measures 
initiative has collected health-related quality of life (HR-QOL), patient satisfaction, 
and functional data after inguinal hernia repair, hip and knee arthroplasty, and varicose 
vein ablation.27 Internationally, the Patient Reported Outcome Measures initiative is 
perhaps the most ambitious quality improvement project to date and has started to 
evaluate the changes in HR-QOL and patient satisfaction after surgery, at the provider 
and institution level.28 In a comparable move, CMS plans to encourage providers and 
institutions to routinely collect PROs data through funding models, such as the 
Meaningful Use and Physician Quality and Reporting System. The funding models 
initially incentivize PROs data collection through physician and institution 
reimbursements; however, after an introductory period, the models penalize 
participants who do not meet reporting/collection requirements. It remains to be 
determined whether routine measurement and comparison of PROs data will improve 
outcomes and lower costs in the long run. 
There are several limitations to this study, many of which are inherent to the 
Delphi process. The qualitative round of the survey was susceptible to influence from 
both the expert panel and the reviewers. To address this, the independent reviewers 
worked separately, without interaction with the expert panel. Final review by the 
expert panel looked for differences between reviewers, which is an accepted method 
for item generation and review and has been implemented by other groups in creating 
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a research agenda.11,29 In addition, the survey was susceptible to nonresponder bias. 
Studies have demonstrated that the demographic characteristics and survey results of 
responders are not equivalent to those of nonresponders.30  There were no qualitative 
differences in occupation between responders and nonresponders; however, there may 
have existed subtle differences between these groups that were not measured. Despite 
this limitation, the survey did receive robust participation for all three rounds, and the 
sample size was comparable to or greater than that of similar conference-based 
surveys.31,32 Finally, the PROS conference relied on patient advocacy groups as a 
surrogate for the ‘patient voice’. Ideally, one could envision incorporating non-
advocacy patients in a national research agenda; however, patient advocates represent 
the best practice currently to promote patient concerns in policy discussions, and this 
study remains one of the few Delphis to incorporate the ‘patient voice’.  Ongoing 
efforts to increase the patient voice in PRO research and implementation will be 
required for meaningful incorporation of PROs into surgical care, measurement and 
research. 
 
CONCLUSION 
In an era of patient-centered care, PROs can serve as a useful complement to ongoing 
discussions on health care expenditures by including the patient voice, and they have 
considerable potential in the determination of quality in an evolving health care 
system. The incredible growth of PROs in clinical care and surgical trials has led to 
many potential research endeavors and collaborations. The PROS Conference 
developed a research agenda for researchers, surgeons, and funding agencies, to help 
prioritize research on PROs measurement in surgery, in order to direct funding and 
institutional collaboration. Future research initiatives should address PROs in the 
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decision-making process, challenges to integrating PROs into the EHR, and PROs and 
the measurement of quality.
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CHAPTER TWO 
When to divert? Defunctioning ileostomy creation during low anterior resection for 
rectal cancer: A decision analysis. 
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CHAPTER TWO 
INTRODUCTION 
Over the past two decades, sphincter preserving surgery has eclipsed 
abdominoperineal resection as the treatment of choice for rectal cancer.1–4 Improved 
screening, surgical technique and multimodality therapy have undoubtedly contributed 
to this trend, yet patient aversion to stomas has remained the foremost catalyst for 
change. Sphincter preservation, however, comes at considerable risk for anastomotic 
leak, which can lead to significant morbidity and mortality. To mitigate this risk, 
proximal diversion of the enteric stream has emerged as the primary procedure to 
reduce both the incidence and severity of anastomotic leaks. Non-randomized 
observational data, as well as one adequately-powered randomized-controlled trial, 
have demonstrated an over 50% reduction in the development of leaks and more than 
90% reduction in associated mortality.5–9 In light of these data, creation of a 
defunctioning ileostomy during low anterior resection is now ubiquitous. 
 Although principally a risk-reducing procedure, temporary defunctioning 
ileostomies are not without risk for morbidity, nor are they always temporary. Recent 
literature has suggested a greater likelihood for readmission for dehydration or stomal 
complications.10–15 A defunctioning ileostomy mandates a second operation for 
reversal, which is itself associated with a small, but not insignificant risk. 
Additionally, patients must accept a temporary lower quality of life (QOL) on the 
grounds that it will reduce the risk and severity of anastomotic leak, and improve their 
long term quantity and quality of life. And yet, not every patient who undergoes low 
anterior resection is at high risk for anastomotic leaks; there may exist a population of 
unnecessary defunctioning stomas. Furthermore, despite a commitment by the patient 
and surgeon to avoid a permanent stoma, some patients may develop metastatic 
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disease or comorbid conditions that preclude reversal of a temporary ileostomy, 
thereby becoming permanent. Growing evidence has shown that anywhere from 10-
30% of defunctioning ileostomies are never reversed.14,16–19  
Regardless of the limitations of existing data, clinical practice has shifted 
towards routine stoma formation during sphincter preserving surgery.4,20 Assimilating 
the risk for anastomotic leak and related mortality with the possibility of stomal 
complications and ileostomy nonreversal, not to mention the QOL implications for 
each strategy, can be difficult to incorporate into preoperative patient discussions. 
There may be clinical scenarios in which the survival and long-term QOL benefit of a 
temporary, defunctioning stoma is negligible. A patient-centered approach to decision-
making would incorporate the risk/benefits of defunctioning ileostomy creation and 
remain responsive to the clinical scenario. To examine the tradeoff between the risks 
and benefits for each strategy, we developed a decision analysis to determine the best 
strategy (defunctioning ileostomy vs no defunctioning ileostomy) during low anterior 
resection for rectal cancer using overall survival and long-term QOL as the primary 
outcome (quality-adjusted life years), and identified clinical variables influential to 
this decision.  
 
METHODS 
Study Design 
We created a decision analytic model to simulate postoperative outcomes after low 
anterior resection for rectal cancer using published guidelines.21–23 We compared the 
strategy of defunctioning ileostomy vs. no defunctioning ileostomy creation, and the 
effect it had on anastomotic and stomal complications (Figure 2.1). The model 
simulated outcomes along three identified phases of postoperative care: 30 days post-
surgery, 90 days post-surgery, and 1 year post-surgery, in which anastomotic leaks for 
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their part occur primarily within the first 30 days, whereas other complications 
including stoma-related may occur within the first 90 days. The primary outcome was 
quality-adjusted life-years (QALYs), which were calculated using health-state utilities 
derived from the literature and the base case life expectancy adjusted for age and 
disease using the Declining Exponential Approximation of Life Expectancy (DEALE) 
method.24 The age- and disease-specific life expectancies were obtained from the 
Centers for Disease Control and Prevention (CDC) Life Tables and the Surveillance 
Epidemiology and End Results (SEER) Cancer Statistics Review.25,26 Utilizing a 
decomposed approach, health outcomes were separated into short- and long-term 
outcomes. Long-term health outcomes were simplified into three categories: no stoma, 
stoma, or death. Short-term outcomes reflected the temporary negative impact of 
complications or reoperations on QOL. The short-term disutility for specific 
complications or procedures were assessed using the average, published length of in-
hospital stay in years, and reflects the loss of time in perfect health.   
The decision tree, model probabilities, and utilities were assessed for clinical validity 
by colorectal surgeons. The decision tree analysis and sensitivity analyses were 
performed using TreeAge Pro 2016 (TreeAge Software, Williamstown, Mass). 
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Figure 2.1 Abridged diagram of the decision tree showing model progression 
and the timeline for outcomes 
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Base Case 
The base case for model analysis was a 65 year-old patient with resectable, stage II-III 
rectal cancer at 8cm from the anal verge, who received standard neoadjuvant radiation 
therapy. Elective low anterior resection was planned with or without a defunctioning 
ileostomy. The technique for specimen removal was total mesorectal excision with 
grossly negative distal and radial margins. The method of resection (i.e. open, MIS, 
MIS-assisted) is not specified and no intraoperative complications occurred. 
Model Assumptions 
For most, if not all decision analyses, model assumptions must be made to simplify a 
clinical scenario into a unified construct and to determine model parameters when 
insufficient or little data exists. In both cases, model assumptions were developed by a 
team of researchers to address these concerns. 
1. Long-term health outcomes: We assumed patients reached their long-term health 
outcome within one year of surgery. Existing high-quality evidence shows that > 
95% of stomas are reversed within 12 months of surgery.19,27,28 To this end, 
patients were assumed to reach three outcomes by the end of year one: no stoma, 
stoma or death. Death in this context refers to complication-related mortality, and 
not as a result of disease. 
2. Complications: To account for differences in the incidence and severity of clinical 
leaks, as well as the morbidity associated with defunctioning ileostomies, we 
separated complications into ‘clinical leaks’ and ‘other complications’. Clinical 
leaks were defined as any signs or symptoms of anastomotic leak requiring 
intervention (antibiotics, percutaneous drainage, or operation) within the first 30 
days. Management of a clinical leak was dichotomized into non-operative 
(antibiotics or percutaneous drainage; Grade A/B anastomotic leak) and operative 
interventions (Grade C anastomotic leak), and does not include potential 
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management of chronic anastomotic leaks such as mucosal advancement flaps, 
fibrin glue, etc. ‘Other complications’ were included only if they were serious 
enough to require readmission within 90 days, which was based on evidence that 
most complications including stoma-related occur within 90 days of 
surgery9,14,17,29,30. The need for reoperation from a complication other than clinical 
leak was assumed to be equivalent between treatment groups. Finally, reoperation 
for a complication other than clinical leak in a patient with an existing stoma such 
as small bowel obstruction, stomal herniation, and fascial dehiscence was assumed 
to result in stoma reversal.  
3. Stoma Formation: We assumed urgent reoperation for a clinical leak would 
uniformly result in the creation of a stoma. This was demonstrated in both the 
Rectal Cancer Trial On DEfunctioning Stoma (RECTODES) study and the Danish 
Colorectal Cancer Group’s database, in which a stoma was consistently created 
during urgent reoperation for clinical leak if there was no defunctioning ileostomy 
during the initial low anterior resection6,31. Urgent reoperation for a clinical leak in 
the presence of an existing defunctioning ileostomy, although unlikely, would not 
intuitively result in reversal of the existing ileostomy at the time of emergent 
reoperation. We refer to a stoma created as a result of urgent reoperation for a 
clinical leak as a ‘secondary stoma’, whereas ileostomy created during index 
operation are referred to as a primary stoma. By defining these as ‘secondary’, we 
are acknowledging the greater likelihood for colostomy or end ileostomy 
formation, which in the literature has shown significantly lower likelihood of 
reversal than loop ileostomy.6,19,27,31–33 
Data Sources 
Model probabilities and utilities used for base case analysis and sensitivity analyses 
were obtained from the literature (Table 2.1 and Table 2.2). A systematic literature 
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search of the Embase/Medline databases from 2005 to 2015 identified articles 
reporting comparative outcomes for defunctioning stoma creation during low anterior 
resection. Preference was given to larger and prospectively-collected data (randomized 
control trials, n ≥ 75; prospective observational cohorts, n ≥ 200; retrospective 
observational cohorts, n ≥ 400). Case studies, case-control studies, and systematic 
literature reviews were excluded. Results were screened for manuscripts that reported 
dichotomized outcomes for defunctioning ileostomy creation during low anterior 
resection. The literature search criteria, results and selected manuscripts are listed in 
Appendix 1 and 2.
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Table 2.1 Model Probability Estimates 
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Table 2.2 Health State Utilities 
 
36 
 
 
T
a
b
le
 2
.2
 H
ea
lt
h
 S
ta
te
 U
ti
li
ti
es
 
37 
 
Other model parameters include complications other than clinical leak 
occurring within the first 90 days, primary vs. secondary stoma reversal, and health 
state utilities after low anterior resection. In order to determine the incidence, 
mortality, length of stay and need for urgent surgery for complications other than 
anastomotic leak, several large observational studies reporting complications after 
large bowel surgery were utilized. Similarly, the incidence of primary or secondary 
stoma reversal at one year, median length of stay and time to stoma reversal was 
obtained from the broader colorectal literature. Health state utilities were obtained 
from manuscripts reporting the postoperative QOL associated with a stoma and/or no 
stoma after low anterior resection through standard methodology (i.e. standard 
gamble, time tradeoff method, or visual analogue scale).  
Sensitivity Analyses 
Model robustness was examined through a series of deterministic sensitivity analyses. 
All model parameters and health state utilities were varied over plausible ranges in 
one-way sensitivity analyses. Sensitive model parameters or utilities were further 
examined through two-way sensitivity analyses when clinically relevant. A three-way 
sensitivity analysis further examined the relationship between three sensitive model 
probabilities.  
RESULTS 
The average life expectancy and quality-adjusted life years for each strategy are listed 
in Table 2.3. For the base case, in which a patient 65 years old with rectal cancer at 8 
cm from the anal verge received neoadjuvant radiation, average life expectancy was 
greater for stoma formation (10.45 vs. 10.32 life years). When adjusted for QOL, 
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stoma formation remained the preferable strategy over no stoma formation (8.81 vs. 
8.77 QALYs); however, equated to only one quality-adjusted life month difference 
between strategies. 
 
Table 2.3 Base case analysis 
 
  Stoma No Stoma Difference 
Life-years 10.45 10.32 0.13 
Quality-adjusted life-years 8.81 8.73 0.08 
        
All model parameters were evaluated through one-way sensitivity analyses 
along there range of plausible values. Sensitive variable are listed in Table 2.4. No 
stoma formation was preferred when the risk for anastomotic leak and leak-related 
mortality was less than 9.0% and 4.1%, when the likelihood of ileostomy reversal was 
less than 70%, and when the predicted QOL with an ileostomy was poor (Health State 
Utility < 0.69). The tornado diagram in Figure 2.2 depicts the influence each model 
parameter has on the expected value (QALYs).  
 
Table 2.4 Sensitive Variables 
 
Model Parameter Threshold 
Clinical leak    8.90%   
Clinical leak mortality    4.10%   
Primary stoma reversal at one-year   70%   
QOL with stoma health state utility   0.69   
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Figure 2.2 Tornado Diagram of model probabilities and utilities 
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Variables sensitive in one-way analyses were further evaluated in two-way sensitivity 
analyses. Figure 2.3 illustrates the interaction between the probability of clinical leak 
and the utility of a permanent stoma, and the probability of clinical leak and leak-
related mortality. A three way analysis of sensitive variables (clinical leak risk, leak-
related mortality and primary stoma reversal) is depicted in Figure 2.4. 
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Figure 2.3 Results of two-way sensitivity analyses 
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Figure 2.3 Results of two-way sensitivity analyses, in which the probability of clinical 
leak and A) the associated mortality, B) the utility of a permanent stoma is varied 
along plausible ranges. The color of the graph plot corresponds to the preferred 
strategy for selected scenario. 
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Figure 2.4 Three-way sensitivity analysis of the probability of clinical leak, leak-
related death and primary stoma reversal at one year. 
 
DISCUSSION 
For the base case, the decision model suggests that creation of a defunctioning 
ileostomy during low anterior resection for rectal cancer results in greater quality and 
quantity of life than no stoma creation. This is consistent with nine meta-analyses and 
one Cochrane review that found ileostomy creation to be a beneficial strategy to 
reduce the incidence and morbidity of anastomotic leaks.34–43 Three recent 
randomized-controlled trials demonstrated a significant reduction in the incidence and 
morbidity of anastomotic leaks; however, only one trial was adequately 
randomized.6,44,45 More recently in a large propensity score matched retrospective 
cohort, ileostomy creation significantly reduced urgent reoperation for anastomotic 
leaks, but did not significantly reduce leak incidence. Despite the abundance of 
existing research, this model represents the first attempt to integrate both the upfront 
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risks associated with anastomotic leaks with the short- and long-term morbidity 
associated with routine stoma formation. After assimilating these risks, the benefit of 
ileostomy creation was modest with only one quality-adjusted life month difference 
between strategies.  Interpreting the significance of this difference is difficult and 
specific to the unique time frame and clinical scenario of this decision. In the setting 
of cancer care, the literature supports a life-expectancy gain of two months as 
significant particularly when a comparable risk reduction in clinical trials would be 
considered clinically significant.46  Although the benefit of stoma formation was 
modest, our model identified clinical scenarios, in which it was the definitive strategy.  
No stoma was favored when the risk for anastomotic leak was less than 9%, when the 
leak-related mortality was less than 4%, when the likelihood of ileostomy reversal was 
less than 70%, and when the QOL with an ileostomy was poor (health state utility < 
0.69). 
The risk for anastomotic leak remains a foremost consideration in the decision 
to create an ileostomy, and it was unsurprising that it played an influential role in our 
model. The interpretation of this value in the clinical setting remains a challenge to 
surgeons as patients rarely present with definitive risk stratification. Unlike predicting 
the risk for stroke in the setting of atrial fibrillation, no risk calculator exists for 
predicting anastomotic leak after low anterior resection. Conversely, risk stratification 
has largely relied on surgeon assessment, which is less a definitive value and more a 
subjective assignment of low, moderate and high risk. There are real consequences to 
reliance entirely on surgeon assessment as a growing body of literature has recognized 
that surgeon risk-taking behavior has a profound impact on their decision-making. In a 
survey of general surgeons, those demonstrating greater tolerance for risk-taking were 
more likely to report common bile duct injuries.47 On the other end of the spectrum, 
risk-averse colorectal surgeons are more likely to create a stoma in response to a series 
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of clinical vignettes.48 In real practice, this may produce considerable variation in the 
treatment strategies among surgeons. Snijders et al. demonstrated this phenomenon 
among hospitals performing colorectal surgery in the Netherlands, in which significant 
variation existed in the formation of stomas during sphincter preserving surgery.20 
Among high and low outlier hospitals, in which the rate of stoma formation ranged 
from 26 to 88%, no significant differences were found in the rate of anastomotic leak 
or mortality even after adjustment for case-mix. Objective determination of 
anastomotic leak risk could optimize patient outcomes after rectal cancer surgery and 
potentially reduce differences in treatment strategies between surgeons. The National 
Surgical Quality Improvement Project currently allows surgeons to determine patient-
specific risk for a core set of postoperative complications, and it is not ill-conceived to 
reason that surgeons would welcome a similar tool to assess anastomotic leak risk. 
Despite current limitations in risk assessment, there exists a large body of 
retrospective data that has identified risk factors for anastomotic leak such as very low 
anastomosis (< 6cm), neoadjuvant radiation, male sex, and intraoperative 
complications.5,6,49,50 In a prospective, Norwegian study, anastomotic height was a 
strong predictor with less than 5% of anastomoses greater than 10cm from the anal 
verge developing an anastomotic leak, whereas the probability was greater than 15% 
for anastomoses less than 6cm.49 From a practical perspective, both this model and the 
results of these observational studies suggest that defunctioning stomas are unlikely to 
be beneficial in patients with high rectal tumors (>10cm) and without preoperative risk 
factors such as radiation, male sex or intraoperative complications.  
The primary aim for this decision analysis was to determine when the risk for 
anastomotic leak and related morbidity and mortality were great enough to warrant a 
temporary loss of QOL with a temporary ileostomy, itself associated with a not 
insignificant morbidity and potential for permanent diversion. To address this, a three-
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way sensitivity analysis was performed of sensitive variables potentially relevant to 
clinical registries: probability of anastomotic leak, anastomotic leak-related mortality 
and ileostomy reversal at one year. For moderate to high risk for clinical leak and 
leak-related mortality, the overwhelming majority of clinical scenarios favored stoma 
formation when the likelihood of ileostomy reversal was greater than 80%. However, 
no ileostomy formation was the preferred strategy for a majority of clinical scenarios 
when the likelihood of stoma reversal was less than 60%. This is particularly 
important when considering the significant variation in defunctioning ileostomy 
reversal (10 – 40%) reported in the literature.14,30,51–53 This analysis suggests that 
reversal of more than 80% of defunctioning ileostomies represents a suitable goal for 
surgeons and institutions to advance patient outcomes. 
Finally, this analysis identified QOL associated with a stoma as an influential 
variable in decision-making. When examined in a two-way analysis, poor QOL 
associated with a stoma was acceptable when the risk for clinical leak was high; 
conversely, if there was marginal clinical benefit, then no stoma creation was 
preferable. Interpreting the importance of health state utilities in clinical practice, 
though, is challenging. Bossema et al. measured the patient perception of stoma QOL 
in patients with and without a stoma, and found significant divergence between groups 
(0.92 vs. 062).54 Of interest, the perception of the QOL with a stoma in patients, who 
had a prior stoma and have been subsequently reversed, approached that of the no 
stoma group. This underscores the importance of response shift, in which difficulties 
from a stoma may not be perceived as serious within the context of cancer treatment.55 
Stoma-related morbidity has not been shown to significantly impact global QOL in 
longitudinal assessments either; however, patients are more likely to report a 
significant impact on function (role, physical and sexual) that recovers after stoma 
reversal.56,57 In preoperative decision-making, discussions should emphasize the 
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impact an ileostomy may have on function (role, physical and sexual) and the likely 
return to their baseline quality of life after reversal. 
There were several limitations to this decision analysis. We chose a decision 
tree over a Markov state transition model based on the relatively short time horizon for 
events. Decision trees are appropriate when clinically important events happen within 
a short, fixed period of time following the decision and when each event generally 
happens only once. However, some patients may develop more than one serious 
complication after surgery. Furthermore, others may develop late complications 
including subclinical leaks, anal stenosis and bowel dysfunction. These complications 
were modeled indirectly through health state utilities, and were the principal reason 
the utility for ‘no stoma’ was less than one. Disutilities were calculated using existing 
analytic methodology, however length-of-stay may not be an appropriate surrogate for 
the disutility of complications in this cohort, and has not been fully investigated.  
 
CONCLUSION 
This decision analysis suggests that the benefits of a defunctioning ileostomy for most 
cases are modest, and underscores the importance of personalizing the treatment 
strategy. The model identified clinical scenarios, in which no stoma was a preferable 
strategy; these scenarios occurred when the risk for clinical leak and leak-related death 
was low, the probability of ileostomy reversal was low, and when the predicted quality 
of life with an ileostomy was poor. This analysis highlights the need for anastomotic 
leak risk stratification tools. Preoperative patient discussions should emphasize a 
patient’s risk for anastomotic leak and ileostomy nonreversal, as well as examine 
patient perceptions of stoma quality of life.   
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APPENDIX 1 
 
Literature Search 
 
Embase/Medline 
2005 – 2016  
('rectal' OR 'rectal' OR 'rectum’ 'rectum') AND  
('neoplasm' OR 'tumor' OR 'cancer' OR 'carcinoma') AND  
('lar' OR 'low anterior resection' OR 'rectum resection' OR 'rectal resection') AND  
(‘defunctioning' OR 'protective') AND  
('ileostomy' OR 'stoma' OR 'ostomy') AND  
 
PRISMA Diagram 
 
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
          
 
 
Records identified through 
database searching 
(n = 379) 
Titles/Abstracts screened 
(n = 285) 
Abstracts excluded 
(n = 263) 
- Not relevant: 156 
- Abstract/Poster only: 49 
- Retrospective < 400: 32 
- Meta-analyses: 9 
- Review: 8 
- Prospective < 200: 6 
- No abstract: 3 
- RCT < 100: 1 
 
Full-text articles assessed for 
eligibility 
(n = 22) 
Full-text articles excluded  
(n = 10) 
- No/Diff comparators: 5 
- No English-language version: 3 
- Repeated data: 2 
Studies included in decision 
analysis 
(n = 12) 
Duplicates excluded 
(n = 94) 
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